{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:50:29Z","timestamp":1781027429233,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s43441-026-00944-w","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:42:30Z","timestamp":1772728950000},"page":"725-735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diving into the Regulatory Landscape of Digital Therapeutics"],"prefix":"10.1007","volume":"60","author":[{"given":"Madhumitha","family":"Masilamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"1","key":"944_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15353702211052280","volume":"247","author":"E Anklam","year":"2022","unstructured":"Anklam E, Bahl MI, Ball R, Beger RD, Cohen J, Fitzpatrick S, et al. Emerging technologies and their impact on regulatory science. Exp Biol Med. 2022;247(1):1\u201375. https:\/\/doi.org\/10.1177\/15353702211052280.","journal-title":"Exp Biol Med"},{"issue":"3","key":"944_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4258\/hir.2022.28.3.188","volume":"28","author":"KY Huh","year":"2022","unstructured":"Huh KY, Oh J, Lee S, Yu KS. Clinical Evaluation of Digital Therapeutics:Present and Future. Healthc Inform Res. 2022;28(3):188\u2013197. https:\/\/doi.org\/10.4258\/hir.2022.28.3.188, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9388922\/.","journal-title":"Healthc Inform Res"},{"key":"944_CR3","unstructured":"Understanding DTx\u2014Digital Therapeutics Alliance. [cited 2025 Apr 21]. Available from: https:\/\/dtxalliance.org\/understanding-dtx\/."},{"key":"944_CR4","doi-asserted-by":"publisher","first-page":"106319","DOI":"10.1016\/j.cmpb.2021.106319","volume":"209","author":"JS Hong","year":"2021","unstructured":"Hong JS, Wasden C, Han DH. Introduction of digital therapeutics. Comput Methods Progr Biomed. 2021;209:106319.","journal-title":"Comput Methods Progr Biomed"},{"key":"944_CR5","doi-asserted-by":"publisher","first-page":"E1200","DOI":"10.1503\/cmaj.1095801","volume":"191","author":"T Lougheed","year":"2019","unstructured":"Lougheed T. How \u201cdigital therapeutics\u201d differ from traditional health and wellness apps. CMAJ Can Med Assoc J. 2019;191:E1200\u20131.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"6","key":"944_CR6","first-page":"685","volume":"29","author":"M Salsabili","year":"2023","unstructured":"Salsabili M, Tesell M, Alcusky M, Greenwood BC, Huang D, Lenz K, et al. Prescription digital therapeutics: applying Medicaid experience to value assessment and formulary management. J Manag Care Spec Pharm. 2023;29(6):685\u201391.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"944_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41746-023-00777-z","volume":"6","author":"C Wang","year":"2023","unstructured":"Wang C, Lee C, Shin H. Digital therapeutics from bench to bedside. NPJ Digit Med. 2023;6(1):38.","journal-title":"NPJ Digit Med"},{"issue":"4","key":"944_CR8","doi-asserted-by":"publisher","first-page":"e0152285","DOI":"10.1371\/journal.pone.0152285","volume":"11","author":"ME Larsen","year":"2016","unstructured":"Larsen ME, Nicholas J, Christensen H. A systematic assessment of smartphone tools for suicide prevention. PLoS ONE. 2016;11(4):e0152285.","journal-title":"PLoS ONE"},{"key":"944_CR9","unstructured":"Conway A. Considerations for the use of artificial intelligence to support regulatory decision-making for drug and biological products guidance for industry and other interested parties DRAFT GUIDANCE. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/guidance-compliance-regulatory-information-biologics\/biologics-guidances."},{"issue":"1","key":"944_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/wps.20592","volume":"18","author":"J Torous","year":"2019","unstructured":"Torous J, Andersson G, Bertagnoli A, Christensen H, Cuijpers P, Firth J, et al. Towards a consensus around standards for smartphone apps and digital mental health. World Psychiatry. 2019;18(1):97.","journal-title":"World Psychiatry"},{"issue":"1","key":"944_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41746-024-01137-1","volume":"7","author":"L Schmidt","year":"2024","unstructured":"Schmidt L, Pawlitzki M, Renard BY, Meuth SG, Masanneck L. The three-year evolution of Germany\u2019s Digital Therapeutics reimbursement program and its path forward. NPJ Digit Med. 2024;7(1):139.","journal-title":"NPJ Digit Med"},{"key":"944_CR12","unstructured":"Nys H. Medical law in Belgium. Kluwer Law International; 2024."},{"issue":"1","key":"944_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41746-024-01232-3","volume":"7","author":"M Aboy","year":"2024","unstructured":"Aboy M, Minssen T, Vayena E. Navigating the EU AI Act: implications for regulated digital medical products. NPJ Digit Med. 2024;7(1):237.","journal-title":"NPJ Digit Med"},{"issue":"4","key":"944_CR14","doi-asserted-by":"publisher","first-page":"e10536","DOI":"10.1002\/btm2.10536","volume":"8","author":"P Phan","year":"2023","unstructured":"Phan P, Mitragotri S, Zhao Z. Digital therapeutics in the clinic. Bioeng Transl Med. 2023;8(4):e10536.","journal-title":"Bioeng Transl Med"},{"key":"944_CR15","doi-asserted-by":"publisher","DOI":"10.2196\/49208","author":"M Kim","year":"2024","unstructured":"Kim M, Patrick K, Nebeker C, Godino J, Stein S, Klasnja P, et al. The Digital Therapeutics Real-World Evidence Framework: an approach for guiding evidence-based digital therapeutics design, development, testing, and monitoring. J Med Internet Res. 2024. https:\/\/doi.org\/10.2196\/49208.","journal-title":"J Med Internet Res"},{"key":"944_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.823977","author":"J Lutz","year":"2022","unstructured":"Lutz J, Offidani E, Taraboanta L, Lakhan SE, Campellone TR. Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content. Front Digit Health. 2022. https:\/\/doi.org\/10.3389\/fdgth.2022.823977.","journal-title":"Front Digit Health"},{"key":"944_CR17","unstructured":"Health Applications Ordinance (DiGAV) Section 1 Eligibility and application content."},{"key":"944_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/TCRM.S489873","volume":"20","author":"A Fassbender","year":"2024","unstructured":"Fassbender A, Donde S, Silva M, Friganovic A, Stievano A, Costa E, et al. Adoption of digital therapeutics in Europe. Ther Clin Risk Manag. 2024;20:939\u201354.","journal-title":"Ther Clin Risk Manag"},{"key":"944_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.12701\/jyms.2024.01004","volume":"42","author":"HJ Shin","year":"2024","unstructured":"Shin HJ, Cho IT, Choi WS, Kim HR, Kang MB, Yang WJ. Digital therapeutics in Korea: current status, challenges, and future directions\u2014a narrative review. J Yeungnam Med Sci. 2024;42:8. https:\/\/doi.org\/10.12701\/jyms.2024.01004.","journal-title":"J Yeungnam Med Sci"},{"key":"944_CR20","unstructured":"Shaik A, Kumar Kanigiri S, Devi Maddi B, Nagabhushanam Maddi V. Regulatory framework for digital therapeutics (DTx) and software as a medical device (SaMD): a global perspective. IJIRT. 2025;12."},{"issue":"7465","key":"944_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12486","volume":"501","author":"JA Anguera","year":"2013","unstructured":"Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, et al. Video game training enhances cognitive control in older adults. Nature. 2013;501(7465):97\u2013101.","journal-title":"Nature"},{"issue":"2","key":"944_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00787-023-02174-z","volume":"33","author":"SA Oh","year":"2024","unstructured":"Oh SA, Choi J, Han DH, Kim EY. Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2024;33(2):481\u201393.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"944_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13012-022-01258-9","volume":"18","author":"JE Glass","year":"2023","unstructured":"Glass JE, Dorsey CN, Beatty T, Bobb JF, Wong ES, Palazzo L, et al. Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implement Sci. 2023;18(1):3.","journal-title":"Implement Sci"},{"key":"944_CR24","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/17434440.2020.1852929","volume":"17","author":"CM Morin","year":"2020","unstructured":"Morin CM. Profile of Somryst prescription digital therapeutic for chronic insomnia: overview of safety and efficacy. Expert Rev Med Devices. 2020;17:1239\u201348.","journal-title":"Expert Rev Med Devices"},{"key":"944_CR25","first-page":"3","volume":"4","author":"G Gussoni","year":"2021","unstructured":"Gussoni G. Digital therapeutics: an opportunity for Italy, and beyond. Tendenze Nuove. 2021;4:3\u20138.","journal-title":"Tendenze Nuove"},{"key":"944_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241277441","author":"P Armeni","year":"2024","unstructured":"Armeni P, Polat I, De Rossi LM, Diaferia L, Meregalli S, Gatti A. Exploring the potential of digital therapeutics: an assessment of progress and promise. Digit Health. 2024. https:\/\/doi.org\/10.1177\/20552076241277441.","journal-title":"Digit Health"},{"issue":"10","key":"944_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/jpm13101523","volume":"13","author":"K Denecke","year":"2023","unstructured":"Denecke K, May R, Gabarron E, Lopez-Campos GH. Assessing the potential risks of digital therapeutics (DTX): the DTX risk assessment canvas. J Pers Med. 2023;13(10):1523.","journal-title":"J Pers Med"},{"key":"944_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2023.1086219","author":"A Watson","year":"2023","unstructured":"Watson A, Chapman R, Shafai G, Maricich YA. FDA regulations and prescription digital therapeutics: evolving with the technologies they regulate. Front Digit Health. 2023. https:\/\/doi.org\/10.3389\/fdgth.2023.1086219.","journal-title":"Front Digit Health"},{"issue":"1","key":"944_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/2666958702101010032","volume":"1","author":"A Dang","year":"2021","unstructured":"Dang A, Dang D, Rane P. The expanding role of digital therapeutics in the post-COVID-19 era. Open COVID J. 2021;1(1):32\u20137.","journal-title":"Open COVID J"},{"key":"944_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.667016","author":"K Yan","year":"2021","unstructured":"Yan K, Balijepalli C, Druyts E. The impact of digital therapeutics on current health technology assessment frameworks. Front Digit Health. 2021. https:\/\/doi.org\/10.3389\/fdgth.2021.667016.","journal-title":"Front Digit Health"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-00944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-00944-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-00944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:26:34Z","timestamp":1777137994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-00944-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-00944-w","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}